- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05802758
CFT-focused Mental Health Intervention With Exposure Training for Youngsters (CFT+VR)
July 30, 2023 updated by: Nina Lindberg, Helsinki University Central Hospital
Compassion-focused Mental Health Intervention With Exposure Training in Virtual Reality for Youngsters Living in an Institution
The aim of this study is to explore if individual CFT-based intervention with exposure training in virtual reality decreases conduct disorder symptoms and callous-unemoitonal traits , as well as increases subjective emotional welbeing among 15-to-20 year-old male prisoners and boys placed to state's residential schools.
We will also study factors that may predict adherence to the intervention.
These factors include mental well-being, motivation, and working alliance.
In addition, we will evaluate the costs of the program.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
144
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Nina Lindberg, PhD
- Phone Number: +358504270028
- Email: nina.lindberg@hus.fi
Study Locations
-
-
-
Helsinki, Finland, 00271
- Recruiting
- State Residential Schools
-
Contact:
- Marko Manninen, PhD
- Phone Number: +358405605090
- Email: marko.manninen@thl.fi
-
Sub-Investigator:
- Mirva Heikkilä, MSc
-
Helsinki, Finland, 00530
- Recruiting
- Prison and Probation Service of Finland
-
Contact:
- Nina Lindberg
- Phone Number: +358504270028
- Email: nina.lindberg@hus.fi
-
Principal Investigator:
- Jenni Kaunomäki, MSc
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
15 years to 20 years (Child, Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Express conduct disorder psychopathology and psychopathic personality traits
- Are placed to a prison or a state residential school for at least 9 months
Exclusion Criteria:
- Females
- Non-Finninsh-speaking
- Remaining in the institution facility less than 9 months
- Intellectual dissability
- Presence of psychotic symptoms
- Autism
- History of epilepsy
- Currently participating another psychotherapeutic intervention
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Youngsters who get CFT + VR
yougsters, who get compassion-focused short intervention together with training in virtual reality together with general psychosocial rehabilitation offered by prisons and state residential schools
|
Psychopathy.comp is a CFT-based manualized program of 20 sessions a 60 min, on a weekly basis.
During the CFT-intervention, partipants try out their new skills in a tailored VR setting (x5)
|
No Intervention: Treatment as usual
youngsters, who get only general psychosocial rehabilitation offered by prisons and state residential schools
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The self-reported change in Youth Pysychopathic traits Inventory- short version (YPI-S) and in the factors of it
Time Frame: 5 months
|
Measures both conduct prolems and psychopathic traits
|
5 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Short Warwick-Edinburgh Wellbeing scale (SWEMWBS)
Time Frame: 5months
|
measures general psychosocial well-being
|
5months
|
Difficulties in Emotion Regulating Scale-Short form (DERS-SF)
Time Frame: 5 months
|
measures emotion regulation style
|
5 months
|
WHO's quality of life questionnaire- Brief version (WHOQOL-BREF)
Time Frame: 5 months
|
measures quality of life
|
5 months
|
Self-Compassion Scale- Short Form (SCS-SF)
Time Frame: 5 months
|
measures self-compassion
|
5 months
|
Santa Clara Compassion Scale
Time Frame: 5 months
|
masures compassion against other people
|
5 months
|
Young Person's Clinical Outcomes in Routine Evaluation (YP-CORE)
Time Frame: 5 months
|
measures how the intervention is felt by the youngster
|
5 months
|
Situational intrinsic and extrinsic motivation scale (SIMS)
Time Frame: 5 months
|
measures younster's motivation to participate the intervention
|
5 months
|
Toronto Alexitymia Scale (TAS-20)
Time Frame: 5 months
|
measures aleksitymia
|
5 months
|
The Personal Feelings Questionnaire- brief version (PFQ-2 Brief)
Time Frame: 5 months
|
measures feelings of quilt
|
5 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Nina Lindberg, PhD, University of Helsinki
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2023
Primary Completion (Estimated)
September 30, 2028
Study Completion (Estimated)
December 31, 2029
Study Registration Dates
First Submitted
March 25, 2023
First Submitted That Met QC Criteria
March 25, 2023
First Posted (Actual)
April 7, 2023
Study Record Updates
Last Update Posted (Actual)
August 1, 2023
Last Update Submitted That Met QC Criteria
July 30, 2023
Last Verified
July 1, 2023
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- HUS/345/2023
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Conduct Disorder
-
Istanbul Bilgi UniversityCenter for Regulation Focused PsychotherapyRecruitingChildhood Externalizing Disorder | Childhood Oppositional Defiant Disorder | Childhood Conduct DisorderTurkey
-
Virginia Commonwealth UniversityNational Institute of Mental Health (NIMH)RecruitingConduct Disorder | Conduct Disorders in Adolescence | Conduct Disorders in Children | Callous-Unemotional TraitsUnited States
-
Finnish Institute for Health and WelfareUniversity of HelsinkiCompletedConduct Disorders in Children
-
National Taiwan University HospitalCompletedAttention Deficit Disorder With Hyperactivity | Conduct Disorders in Adolescence | Autistic Spectrum DisorderTaiwan
-
Oregon Research Behavioral Intervention Strategies...RecruitingConduct Disorder | Oppositional Defiant DisorderUnited States
-
Region SkaneRecruitingGambling Disorder | Gaming DisorderSweden
-
Indonesia UniversityRadboud University Medical CenterNot yet recruiting
-
Karolinska InstitutetDeakin UniversityRecruiting
-
Taipei City HospitalRecruiting
-
University Hospital, LilleMinistry of Health, FranceNot yet recruiting
Clinical Trials on Psychopathy.comp and training in virtual reality (VR)
-
University of California, Los AngelesRecruiting
-
Baylor Research InstituteCompletedAcquired Brain Injury
-
Cairo UniversityRecruitingRotator Cuff Injuries | Rotator Cuff Tears | Rotator Cuff Impingement SyndromeEgypt
-
University of NebraskaRecruitingHemiplegic Cerebral PalsyUnited States
-
Tel-Aviv Sourasky Medical CenterCompletedMultiple SclerosisIsrael, United States
-
University Health Network, TorontoMichael Garron Hospital; Centre for Aging and Brain Health InnovationTerminatedDementia | Delirium Superimposed on DementiaCanada
-
Imperial College LondonRecruitingHearing Loss | Aminoglycoside Toxicity | Video Games | Aminoglycoside-Induced Hearing LossUnited Kingdom
-
Second Affiliated Hospital of Wenzhou Medical UniversityTerminatedImmersion Virtual Reality Training ,Stroke, Upper Extremity, Randomized Controlled TrialChina
-
OHSU Knight Cancer InstituteOregon Health and Science UniversityCompletedHematopoietic and Lymphoid Cell Neoplasm | Malignant Solid NeoplasmUnited States
-
University of NebraskaRecruiting